Objectives: Actical ® actigraphy is commonly used to monitor athlete sleep. The proprietary software, called Actiware ® , processes data with three different sleep-wake thresholds (Low, Medium or High), but there is no standardisation regarding their use. The purpose of this study was to examine validity and bias of the sleep-wake thresholds for processing Actical ® sleep data in team sport athletes.
Introduction
Sleep is widely accepted as a critical component of the recovery process for an elite athlete. 1, 2 As such, monitoring an athlete's sleep has become commonplace as sport scientists look for ways to improve sleep, recovery, and optimise performance. Monitoring sleep using the accepted gold standard method of polysomnography (PSG) is impractical for most athletes since it requires specialist equipment and staff to collect and analyse the data.
Also, because PSG monitoring often requires the subject to sleep in a laboratory or setting outside their home environment, long term monitoring of an individual's sleep, or monitoring multiple athletes simultaneously is problematic. For these reasons, actigraphy has become a popular low-cost, non-invasive alternative for collecting sleep data of athletes. Worn on the wrist, actigraph monitors contain a multidirectional accelerometer that detects movements and employs software algorithms to distinguish sleep from wakefulness based on the level of movement. 3 These small devices can store several days and nights of data before downloading to a computer, allowing users to monitor multiple athletes over consecutive nights in any environment; home or away at competition.
The Actical ® (Philips Respironics) is an actigraph commonly employed by sport scientists to monitor sleep behaviour in elite athletes. 2, 4 Data from the Actical ® device can be converted into a format which allows for processing with the Actiware ® analysis software (Philips Respironics). This software uses algorithms to process data based on one of three Actiware ® sleep-wake threshold settings (Low, Medium and High). Although the sleep-wake threshold algorithms were originally developed and validated with sleep disordered patients, the algorithms and Actical ® devices have been validated on a range of populations including sleep disordered and healthy adults. [5] [6] [7] [8] There is however, currently no standardised protocol regarding the use of different threshold settings.
Previous research studies investigating the sleep behaviour of elite athletes have used the Medium sleep-wake threshold, based on the work of other industry researchers using this threshold setting. 2, 4 Recently, researchers compared the validity of wrist actigraphy across all three Actiware ® threshold settings in elite endurance cyclists. 1 Whilst good agreement was observed between activity monitors and PSG for each of the three sleep-wake thresholds (81-90%), the devices underestimated sleep duration and overestimated wake duration depending on which threshold was applied. In contrast to studies using the Medium threshold, Sargent et al. (2015) recommended the High sleepwake threshold be employed when using Actical ® actigraphy with elite cyclists.
Considering the widespread use of actigraphy with elite athletes, we sought to expand to work of Sargent et al. (2015) to include elite team-sport athletes. Due to the lack of standardisation of the sleep-wake threshold settings used to analyse Actical ® data, the aim of this study was to examine the validity and potential bias of the three software thresholds compared with polysomnography. Also, given the way the actigraphy and PSG data is used in a practical setting, only time matched, overall night data values were used for comparison rather than an epoch to epoch analysis which has been used by previous researchers. 3, 7 
Methods
Participants were 21 male elite team-sport athletes (age: 22.5 ±2.7y) from the premier Australian Rules Football League (10) and Australian Rugby League (11) .
Participants completed a Pittsburgh Scale for Evaluation of Sleep Quality questionnaire to establish inclusion in the study. 9 Exclusion criteria included; shift workers, participants on medication which could impact study results, parents with newborns, presence of primary sleep disorders, and consumption of more than five caffeine beverages per day. Informed consent was obtained from each participant and the study was approved by the Ethics Committees of Murdoch University and the Australian Institute of Sport.
Participants' sleep was assessed using PSG and concurrent actigraphy on four occasions. All athletes were in pre-season training at the time of the study. Data was collected as part of an intervention sleep study which was a randomised, parallel group, single blind experimental design comparing neurofeedback to a sham group. Sixty-seven successful observations were recorded, after some recordings were excluded due to technical issues (n = 16) or participant illness (n = 1). All participants slept in their own bedroom within an apartment. Bedtimes and awakening times were ad libitum; however, the time when bedroom lights were turned off (bedtime) and on (awakening time) was noted.
Clocks on the PSG and Actical ® devices were synchronised to align the two recording hand; oronasal airflow sensor; and a single modified lead 11 placement for electrocardiogram (ECG). Signals from each PSG system were stored in a data card within the system as well as transmitted to a laptop in an adjacent room where a researcher monitored the signals throughout the night. All data was scored in 30 s epochs according to the American Academy of Sleep Medicine scoring criteria by a trained specialist, unaware of the participants' intervention condition. 10 The studies were reviewed according to the same criteria by a second sleep specialist blinded to the study design.
Actigraphy data were collected using Actical ® Z series activity monitors (Actical ® Z series part number 198-0200-03; Philips Respironics, Oregon, USA) worn on the nondominant wrist. Each activity monitor contains a 3-axis piezoelectric accelerometer sampled at 32 Hz, which generates a voltage when it undergoes a change in acceleration. Sensitive to movements in the 0.5Hz to 3Hz range, the Actical ® device records the mean of activity, or movement, sampled each second with the means summed to create activity counts for each 1 minute epoch. Actiware ® 5.61 activity and sleep analysis software (Mini Mitter Philips/Respironics, Oregon, USA) was used to set up, download and process the data. An activity score was generated for each epoch as a weighted average of the activity count for the current epoch and that of the surrounding epochs (±2 min). 11 Data from the Actical ® was assessed as sleep or wake based on whether or not the activity scores exceeded a set wake sensitivity threshold. For the purpose of this study, data from the actigraph devices was processed for all three wake sensitivity thresholds; Low (> 20 activity counts scored as wake), Medium (> 40 activity counts scored as wake), High (> 80 activity counts scored as wake). Time in bed was calculated using the 'lights off' and 'lights on' times recorded on the PSG system. SOL was calculated as the time from lights out until sleep onset and as such, the results for this sleep parameter do not change across the three sleep-wake thresholds.
In previous studies, agreement rates of epoch-by-epoch data have been used to compare PSG and actigraphy, however this technique is not considered fully appropriate as a measure of concordance. 3, 12 , very large (0.7-0.9). 13 Bland-Altman plots of absolute error in Actical ® from the mean of the PSG and Actical ® data across all sleep parameters were conducted. 14 
Results
Data comparing the three sleep-wake threshold settings on the Actical ® devices to PSG are presented in Table 1 . Bland-Altman plots comparing PSG to Actical ® for each sleep-wake threshold are depicted in Figure 1 The average amount of time athletes spent awake after sleep onset was overestimated by an average of 15.9 min using the Low threshold. Conversely, the Actical ® devices underestimated wake time on the Medium and High thresholds by 4.1 and 19.3 min respectively. As with sleep efficiency, a low correlation to PSG was observed for the Low threshold (r=0.24) and a moderate correlation was observed for the Medium and High thresholds (r=0.33 and 0.37) and the SEE was similar across thresholds. Compared to PSG, the Actical ® monitor underestimated the number of wake bouts regardless of the sleep-wake threshold employed, however these results were not significantly different from that obtained from PSG. As with the other sleep parameters, the SEE for all thresholds was practically the same, however the Low threshold produced the smallest mean bias. A low correlation with PSG was observed with r values of 0.20 for Low, 0.12 for Medium and 0.16 for High thresholds. The Actical ® devices underestimated sleep latency by an average of 9.5 min with a SEE of 15.2 min. The results for this sleep parameter were the same across the three thresholds and a low correlation to PSG was observed (r = 0.24).
Discussion
In a sport setting, Actical ® devices are commonly used to identify athletes requiring further education or intervention about their sleep hygiene, and are also used in research settings as a measure of sleep quantity and quality. 2, 4 The results of this study indicate that for elite team-sport athletes the interpretation of the Actical ® data, and therefore feedback to athletes, can vary widely depending on the Actiware ® software threshold used to process the data. In the present study, the Medium sleep-wake threshold of the Actiware ® software produced the smallest mean bias compared with PSG for sleep duration, sleep efficiency and wake after sleep onset. These findings are in contrast to that of Sargent et al. (2015) , who reported that the High threshold produced the smallest differences for the same sleep parameters compared to the PSG for elite endurance-trained cyclists. Our results are also in contrast to other validation studies using the Actical ® device with non-athletic populations which have recommended using the Low or very low (activity count = 10) thresholds for better overall performance compared with PSG. 6, 7 The differences between the findings of the present study conducted on elite teamsport athletes and those of other validation studies noted above may relate to the different subject groups and conditions in which studies were conducted. Sargent (2015) Collectively the results of the current and previous validation studies highlight that, compared with PSG, actigraphy has limitations when applied to different athletic or nonathletic populations and should be interpreted with caution. One limitation of the present study was that only male athletes were used and as such, similar validation studies should be conducted on female athletes. However, given the varying results of the aggregated validation studies, the data on women may also be confounded by similar factors such as the type of athlete (endurance or team-sport), training phase, and if the data is collected in a private residence or a sleep laboratory.
The present study found that compared to PSG, the athletes' total sleep time (447 min) and sleep efficiency were underestimated on the Low threshold (~12 min) and overestimated with the Medium (~9 min) and High (~24 min) thresholds. In an applied sense, the latter error of about five percent is substantial. The practical relevance of the errors compared with PSG are larger for WASO (41 min), which was underestimated when the Medium (~37 min) and High (~22 min) thresholds were applied, and overestimated using the Low (~31 min) threshold. Indeed the value from the High threshold is approximately half that from PSG and would lead to a different interpretation of an athlete's sleep. Furthermore, regardless of the threshold applied, the Actical ® devices significantly underestimated sleep onset latency by an average of 9.5 mins. Considering a normal sleep latency period is 10-20 mins, a bias of this magnitude is important when attempting to interpret sleep reports. In addition to these observed biases, it is important to note that in the present study the correlations between the actigraphy and PSG for all sleep parameters, other than total sleep time, are only low to moderate. One of the limitations of actigraphy is that it uses movement or lack of movement as a surrogate to infer a state of wakefulness or sleep respectively 12 , whereas PSG detects wakefulness and sleep using brain wave activity rather than subject mobility.
As well as investigating the potential systematic bias of each threshold on the different sleep parameters, another objective of the study was to understand the uncertainty 
Conclusions
Results from the present study suggest that whilst the 'noise' or imprecision of measures from the Actical ® devices is similar for the different sleep-wake thresholds, there is less bias associated with the Medium threshold for sleep duration, sleep efficiency and WASO. Therefore, scientists using Actical ® devices to monitor sleep in elite team-sport athletes should consider using thresholds that are moderately sensitive to sleep (Medium threshold)
where activity counts are above 40. Additional validation studies of the Actical ® devices with elite athlete populations, including female athletes, should be undertaken to understand the bias and imprecision of the different sleep-wake threshold settings on data analysis.
Practical Implications
 Sleep reports and research using the Actical ® devices should indicate which sleep-wake threshold was used to process the data.
 A Medium sleep-wake threshold (activity counts above 40) should be used to process sleep data for team sport athletes.
 The imprecision of actigraphy highlights the importance of utilising confidence limits to assess the likelihood of a real change between sleep measures over time. Fig. 1 Bland-Altman plots comparing PSG with the Actical ® devices at different sleep-wake thresholds (Low, Medium and High) for total sleep time, sleep efficiency, wake after sleep onset, wake bouts and sleep onset latency. The solid lines indicate the mean bias from PSG and the broken lines indicate 95% limits of agreement (±1.96 SDs). ACT -Actical ®, PSGpolysomnography. 
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